CRSP Competitors & Alternatives
Compare Crispr Therapeutics AG with similar stocks in the same industry
Biotechnology
CRSP
Main Stock$49.27
Tradestie Score
52
Market Cap
$6.02B
Revenue Growth
10.4%
Analyst Upside
+73.8%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AXSM
Axsome Therapeutics, Inc
|
$145.24
|
$5.92B | - | 43 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$54.72
|
$5.80B | 19.3 | 57 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$312.33
|
$5.20B | 40.1 | 49 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$60.91
|
$4.94B | - | 38 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$60.32
|
$4.93B | - | 45 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$57.99
|
$4.84B | - | 61 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$138.15
|
$3.98B | 134.1 | 58 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.95
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$110.95
|
$3.91B | - | 49 | Compare |
More CRSP Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
221 stocks in this industry